While our in vitro experiments in blocking PD-1 in PBMC samples isolated before radiotherapy provide further support for targeting PD-1 and its ligand in cervical cancer, this was hardly the case after the initiation of radiotherapy. The gene discussed is PDCD1; the disease is cervical carcinoma.